You just read:

Amsterdam Molecular Therapeutics' Glybera(R) Significantly Reduces the Risk of Pancreatitis in LPLD Patients

News provided by

Amsterdam Molecular Therapeutics B.V

29 Jun, 2011, 06:00 BST